RBV Capital

RBV Capital is a dedicated life sciences venture fund based in Moscow, Russia with partnership office in Wilen, Switzerland. We invest into diversified assets in pharmaceuticals, biologics, digital healthcare products and medical devices answering to an unmet medical and market need and with a potential for global outreach.

Igor Gonikhin

Investment Director

Robert Karl

Partner

Alexey Konov

Partner

Alexander Martynov

Associate

Past deals in Russia

Botkin.AI

Series B in 2020
Botkin.AI is a software platform specializing in medical image processing and analysis through artificial intelligence. Founded in 2015 and based in Moscow, the company focuses on enhancing the capabilities of radiologists by providing advanced tools for analyzing radiograms and assessing the risk of tumors. Utilizing deep machine learning, Botkin.AI's technology enables healthcare providers to diagnose oncological diseases, such as lung cancer, with high accuracy and at early stages. By streamlining the processing of clinical data, the platform improves diagnostic efficiency while maintaining the quality of medical conclusions, ultimately supporting better patient outcomes.

Botkin.AI

Series A in 2019
Botkin.AI is a software platform specializing in medical image processing and analysis through artificial intelligence. Founded in 2015 and based in Moscow, the company focuses on enhancing the capabilities of radiologists by providing advanced tools for analyzing radiograms and assessing the risk of tumors. Utilizing deep machine learning, Botkin.AI's technology enables healthcare providers to diagnose oncological diseases, such as lung cancer, with high accuracy and at early stages. By streamlining the processing of clinical data, the platform improves diagnostic efficiency while maintaining the quality of medical conclusions, ultimately supporting better patient outcomes.